Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap.
In This Week’s Edition, We Recap and Countdown the Top 10 Cannabis and Psychedelic Stock News Stories for the Week of March 29th – April 4th, 2021.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view the full article.
In Today’s Earnings Recap We’ll Be Reviewing the Most Recent Quarterly Financial Results and Corresponding Earnings Conference Calls of the Big 4 U.S. MSOs, Also Known as the “4 Bosses of #MSOGang”
Without further delay, let’s take a closer look at the fourth quarter and full-year 2020 earnings from Curaleaf (OTCQX: CURLF), Trulieve (OTCQX: TCNNF), Green Thumb (OTCQX: GTBIF) and Cresco Labs (OTCQX: CRLBF).
The “Right” Thing to Say Would Be That By Investing in Psychedelics, We’re Investing in the Next Evolution of Mental Health Medicines and Therapies
Despite a recent downturn in the broader markets, as well as a sell-off in the Psychedelics space – those who got in early on the big-name Psychedelic Stocks such as MindMed (OTCQB: MMEDF), Compass Pathways (NASDAQ: CMPS) and Field Trip Health (OTC: FTRPF) are still money-good. Of course, these numbers don’t mean much right now. After all, these companies haven’t even scratched the surface in terms of what they’re going to accomplish over the next three to five years. In other words, the big money has not yet been made on these stocks.
Demand for RWB’s Platinum Vape Branded Products Continues to Soar, With PV Reporting Record Michigan Sales of Roughly USD $6.5 Million for the Month of February